tricalcium phosphate has been researched along with Soft Tissue Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Docherty, LM; Gupta, S; Halai, M; Mahendra, A; Razii, N | 1 |
| Hes, O; Kazakov, DV; Michal, M; Shelekhova, KV; Treska, V | 1 |
2 other study(ies) available for tricalcium phosphate and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Injectable Synthetic Beta-Tricalcium Phosphate/Calcium Sulfate (GeneX) for the Management of Contained Defects Following Curettage of Benign Bone Tumours.
Topics: Adult; Bone Neoplasms; Bone Substitutes; Calcium Sulfate; Curettage; Female; Humans; Male; Neoplasm Recurrence, Local; Soft Tissue Neoplasms | 2023 |
Phosphaturic mesenchymal tumor (mixed connective tissue variant): a case report with spectral analysis.
Topics: Adult; Alkaline Phosphatase; Calcium; Calcium Phosphates; Humans; Hypophosphatemia; Male; Mesenchymoma; Microscopy, Electron; Nitrates; Soft Tissue Neoplasms; Spectrometry, X-Ray Emission | 2006 |